Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Myocardial Infarction, Deep Venous Thrombosis, and Pulmonary Embolism in SARs-CoV-2 Hospitalizations; Insights from the National Inpatient Sample 2020

Version 1 : Received: 17 July 2023 / Approved: 17 July 2023 / Online: 19 July 2023 (04:41:51 CEST)

How to cite: Evbayekha, E.; Okorare, O.; Alugba, G.; Willie, A.; Omosumwen, E.; Emeasoba, C.M.; Salaudeen, B.H.; Onyekwere, A.O.; Agho, A.V.; Okunromade, O.; Busari, A.K.; Akinsete, A.O.; Emore, E.; Sanusi, I.A.; Nnaemeka, A.; Odoma, V.A.; Ugonma, L.; Okobi, E.K.; Okobi, O.E. Myocardial Infarction, Deep Venous Thrombosis, and Pulmonary Embolism in SARs-CoV-2 Hospitalizations; Insights from the National Inpatient Sample 2020. Preprints 2023, 2023071113. https://doi.org/10.20944/preprints202307.1113.v1 Evbayekha, E.; Okorare, O.; Alugba, G.; Willie, A.; Omosumwen, E.; Emeasoba, C.M.; Salaudeen, B.H.; Onyekwere, A.O.; Agho, A.V.; Okunromade, O.; Busari, A.K.; Akinsete, A.O.; Emore, E.; Sanusi, I.A.; Nnaemeka, A.; Odoma, V.A.; Ugonma, L.; Okobi, E.K.; Okobi, O.E. Myocardial Infarction, Deep Venous Thrombosis, and Pulmonary Embolism in SARs-CoV-2 Hospitalizations; Insights from the National Inpatient Sample 2020. Preprints 2023, 2023071113. https://doi.org/10.20944/preprints202307.1113.v1

Abstract

Background: We studied the outcomes of SARS-CoV-2 (COVID) hospitalizations and their association with myocardial injury and thrombosis. Methods: Retrospective analysis of the National Inpatient Sample 2020 database. Results: We identified 335,799 hospitalizations with COVID. Of these, 1.6% (5,355) were diagnosed with non-ST-segment myocardial infarction (COVNSTEMI). The mean age of COVID hospitalizations was 71.7, with 60.50% being males. The population prevalence included 53.10% Whites, 17.80% Blacks, 19.20% Hispanics, and 4.10% Asians. The average length of stay (LOS) was 10 days, and 37.60% of patients died during their hospitalization. The average cost of hospitalization (TOTCHG) was $156,633. The COVSTEMI group comprised 1,364 cases, with a mean age of 67.4, in-hospital mortality of 47.4%, and the mean TOTCHG was $177,600. The DVTCOV group comprised 2,869 cases, while the PECOV group had 4,828 cases. Male predominance was observed in both groups, with mean ages of 66 years in the DVTCOV group and 64 years in the PECOV group. The DVTCOV group had a LOS of 16 days, with 24.71% mortality, while the PECOV group had a LOS of 11 days, with 19.20% mortality. The average TOTCHG in the DVTCOV group was $248,900, whereas it was $145,378 in the PECOV group. Conclusion: Our study revealed significant mortality rates across different groups, including 38% in COVNSTEMI, 47% in COVSTEMI, 25% in DVTCOV, and 19% in PECOV. These findings highlight the severity of COVID-related complications and the substantial financial burden of hospitalization.

Keywords

SARS‐CoV‐2;  COVID‐19;  Pulmonary  embolism;  PE;  deep  venous  thrombosis;  DVT;  hospitalization

Subject

Medicine and Pharmacology, Cardiac and Cardiovascular Systems

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.